Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study

Sanne Maria Henriette Zweijpfenning; Raphael Chiron; Sharon Essink; Jodie Schildkraut; Onno W. Akkerman; Stefano Aliberti; Josje Altenburg; Bert Arets; Eva van Braeckel; B. nédicte Delaere; Sophie Gohy; Eric Haarman; Natalie Lorent; Genevieve McKew; Lucy Morgan; Dirk Wagner; Jakko van Ingen; Wouter Hoefsloot

doi:https://doi.org/10.1016/j.chest.2022.01.015

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study

Sanne Maria Henriette Zweijpfenning, Raphael Chiron, Sharon Essink, Jodie Schildkraut, Onno W. Akkerman, Stefano Aliberti, Josje Altenburg, Bert Arets, Eva van Braeckel, B. nédicte Delaere, Sophie Gohy, Eric Haarman, Natalie Lorent, Genevieve McKew, Lucy Morgan, Dirk Wagner, Jakko van Ingen, Wouter Hoefsloot

Research output: Contribution to journal › Article › Academic › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	76-81
Number of pages	6
Journal	Chest
Volume	162
Issue number	1
DOIs	https://doi.org/10.1016/j.chest.2022.01.015
Publication status	Published - 1 Jul 2022

Access to Document

https://doi.org/10.1016/j.chest.2022.01.015

Cite this

Henriette Zweijpfenning, S. M., Chiron, R., Essink, S., Schildkraut, J., Akkerman, O. W., Aliberti, S., Altenburg, J., Arets, B., van Braeckel, E., Delaere, B. N., Gohy, S., Haarman, E., Lorent, N., McKew, G., Morgan, L., Wagner, D., van Ingen, J., & Hoefsloot, W. (2022). Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study. Chest, 162(1), 76-81. https://doi.org/10.1016/j.chest.2022.01.015

@article{4183f322956946edb96ad6a05e455175,

title = "Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study",

author = "{Henriette Zweijpfenning}, {Sanne Maria} and Raphael Chiron and Sharon Essink and Jodie Schildkraut and Akkerman, {Onno W.} and Stefano Aliberti and Josje Altenburg and Bert Arets and {van Braeckel}, Eva and Delaere, {B. n{\'e}dicte} and Sophie Gohy and Eric Haarman and Natalie Lorent and Genevieve McKew and Lucy Morgan and Dirk Wagner and {van Ingen}, Jakko and Wouter Hoefsloot",

note = "Funding Information: Funding/support: Nonfinancial support was provided by Insmed.",

year = "2022",

month = jul,

day = "1",

doi = "https://doi.org/10.1016/j.chest.2022.01.015",

language = "English",

volume = "162",

pages = "76--81",

journal = "Chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "1",

}

Henriette Zweijpfenning, SM, Chiron, R, Essink, S, Schildkraut, J, Akkerman, OW, Aliberti, S, Altenburg, J, Arets, B, van Braeckel, E, Delaere, BN, Gohy, S, Haarman, E, Lorent, N, McKew, G, Morgan, L, Wagner, D, van Ingen, J & Hoefsloot, W 2022, 'Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study', Chest, vol. 162, no. 1, pp. 76-81. https://doi.org/10.1016/j.chest.2022.01.015

TY - JOUR

T1 - Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease

T2 - A NTM-NET study

AU - Henriette Zweijpfenning, Sanne Maria

AU - Chiron, Raphael

AU - Essink, Sharon

AU - Schildkraut, Jodie

AU - Akkerman, Onno W.

AU - Aliberti, Stefano

AU - Altenburg, Josje

AU - Arets, Bert

AU - van Braeckel, Eva

AU - Delaere, B. nédicte

AU - Gohy, Sophie

AU - Haarman, Eric

AU - Lorent, Natalie

AU - McKew, Genevieve

AU - Morgan, Lucy

AU - Wagner, Dirk

AU - van Ingen, Jakko

AU - Hoefsloot, Wouter

N1 - Funding Information: Funding/support: Nonfinancial support was provided by Insmed.

PY - 2022/7/1

Y1 - 2022/7/1

UR - http://www.scopus.com/inward/record.url?scp=85133638453&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.chest.2022.01.015

DO - https://doi.org/10.1016/j.chest.2022.01.015

M3 - Article

C2 - 35063454

SN - 0012-3692

VL - 162

SP - 76

EP - 81

JO - Chest

JF - Chest

IS - 1

ER -

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study

Access to Document

Other files and links

Cite this